Total Funding
58
53
Total FundingCorporate Round raised
Growth Score 58 in past quarter
-4 pts
Heat Score 53 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
69382
Vaporox is a medical device startup that uses the technology to treat diabetic foot ulcers and skin wounds.
- Alan Sage: CEO and PresidentPast Role: Documoto, Founder and CEO
- Loren Hutchins: Chief Product Officer
About the Company
Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT), a patented and FDA-510(k)-cleared technology that represents a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs), as well as amputations, burns, frostbite, gangrene, pressure ulcers (bed sores), and skin grafts.
